Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylprednisolone acetate
Drug ID BADD_D01434
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D00979
MeSH ID D000077555
PubChem ID 5877
TTD Drug ID Not Available
NDC Product Code 0009-0026; 10695-041; 38779-0144; 46439-8767; 82298-117; 0009-0274; 50090-6024; 60219-1574; 0009-0306; 68788-8082; 76420-262; 0781-3516; 51552-0958; 0009-3073; 76420-260; 25021-821; 0009-0280; 50090-0436; 49452-4688; 71052-161; 25021-820; 70121-1552; 76420-081; 60722-1007; 0009-3475; 55150-313; 63187-474; 70121-1573; 70121-1574; 52128-148; 42023-239; 42023-240; 55150-314; 51927-0000; 63275-9942; 65089-0016; 50090-0556; 51662-1429; 22552-0023; 50090-5894; 60219-1573
UNII 43502P7F0P
Synonyms Methylprednisolone Acetate | Methylprednisolone-21-acetate | Methylprednisolone 21 acetate | Acetyl-Methylprednisolone | Acetyl Methylprednisolone | Depo-Medrone | Depo Medrone | Depo-Medrol | Depo Medrol | Methylprednisolone Acetate, (11beta,16beta)-isomer | Methylprednisolone Acetate, (11beta,16alpha)-isomer
Chemical Information
Molecular Formula C24H32O6
CAS Registry Number 53-36-1
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cardiac failure congestive02.05.01.002--Not Available
Cardiomegaly02.04.02.001--Not Available
Cataract06.06.01.001--
Cataract subcapsular06.06.01.002--Not Available
Circulatory collapse24.06.02.001--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Cushingoid24.08.02.004; 19.07.03.001; 14.11.01.006; 05.01.01.002--
Delusion19.10.01.001--
Depressed mood19.15.02.001--Not Available
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Dermatitis allergic23.03.04.003; 10.01.03.014--Not Available
Diabetes mellitus14.06.01.001; 05.06.01.001--Not Available
Diarrhoea07.02.01.001--
Diplegia17.01.04.015--Not Available
Discomfort08.01.08.003--Not Available
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Drug dependence19.07.06.011--Not Available
Dry skin23.03.03.001--
Dyspepsia07.01.02.001--
Ear disorder04.03.01.001--Not Available
Ecchymosis24.07.06.002; 23.06.01.001; 01.01.03.001--Not Available
Endocrine disorder05.09.01.001--Not Available
Erythema23.03.06.001--Not Available
Euphoric mood19.04.02.006--
Exophthalmos06.09.04.001; 05.02.02.002--Not Available
Eye allergy10.01.03.028; 06.04.05.010--Not Available
Eye disorder06.08.03.001--Not Available
Eye inflammation06.04.05.002--Not Available
Fat embolism24.01.01.012; 12.01.08.003--Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 8 Pages